Gene polymorphisms of TNF-238G/A, TNF-308G/A, IL10-1082G/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis

J Med Life. 2018 Jan-Mar;11(1):69-74.

Abstract

Rationale.Psoriasis is a prevalent chronic inflammatory disease with worldwide distribution affecting approximately 2% of the Caucasian population. There have been many population- and family-based studies that agree on the strong genetic component of this disease. Several studies have investigated the relationship between cytokine gene polymorphisms, psoriasis, and the occurrence of comorbidities but their data are conflicting. Objective.This study examines cytokine gene single-nucleotide polymorphisms (SNPs) in the context of psoriasis and metabolic syndrome, with a focus on the occurrence of comorbidities in psoriasis patients. The working hypothesis is that particular SNPs may predispose to an accelerated disease course and more comorbidities in psoriasis patients. Methods:This cross-sectional study was carried out in 2016 in the Dermatology Department of "Elias" University Emergency Hospital, Bucharest and included 82 psoriasis patients. Several clinical and laboratory parameters were recorded, and the presence of metabolic syndrome (MetS) was noted. Using real-time PCR, we tested for the following SNPs: rs361525, rs1800629, rs1800896, rs610604, rs17782313. Results:Disease severity was not significantly influenced by any of the five studied SNPs. Gene polymorphism of rs17782313 was found to influence the occurrence of psoriatic arthritis. In these patients, rs610604 and rs17782313 polymorphisms were associated with the presence of diabetes mellitus. Furthermore, rs17782313 influenced the presence of obesity, heterozygotes being more at risk. Our data suggested that MetS occurred independently of the five studied SNPs. Discussion.The influence of certain cytokine gene polymorphisms on multiple organ systems is justification enough for further analysis of the genetic and molecular mechanisms of metabolic syndrome development in psoriasis patients. Abbreviations:single-nucleotide polymorphisms - SNPs, metabolic syndrome - MetS.

Keywords: Comorbidity; Cytokines; Metabolic Syndrome; Polymorphism; Psoriasis; Single Nucleotide.

MeSH terms

  • Adult
  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / epidemiology
  • Arthritis, Psoriatic / genetics
  • Comorbidity
  • Cross-Sectional Studies
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / genetics
  • Female
  • Fibrinogen / metabolism
  • Genetic Predisposition to Disease*
  • Heterozygote
  • Humans
  • Interleukin-10 / genetics*
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / genetics
  • Middle Aged
  • Obesity / blood
  • Obesity / epidemiology
  • Obesity / genetics
  • Polymorphism, Single Nucleotide / genetics*
  • Psoriasis / blood
  • Psoriasis / epidemiology
  • Psoriasis / genetics*
  • Psoriasis / pathology
  • Receptor, Melanocortin, Type 4 / genetics*
  • Risk Factors
  • Romania / epidemiology
  • Severity of Illness Index
  • Tumor Necrosis Factor alpha-Induced Protein 3 / genetics*
  • Tumor Necrosis Factor-alpha / genetics*
  • White People

Substances

  • MC4R protein, human
  • Receptor, Melanocortin, Type 4
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Fibrinogen
  • TNFAIP3 protein, human
  • Tumor Necrosis Factor alpha-Induced Protein 3